Nicolaï Grebenchtchikov

High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.

John A. Foekens, Harry A. Peters, Nicolaï Grebenchtchikov et al. · PubMed · 2001 · 300 citations · Full text

Medicine, Oncology, Pharmacology +17

Immunochemical and Mass-Spectrometry–Based Serum Hepcidin Assays for Iron Metabolism Disorders

Joyce JC Kroot, Coby M. Laarakkers, Anneke Geurts‐Moespot et al. · Clinical Chemistry · 2010 · 196 citations · Full text

Medicine, Biochemistry, Clinical Biochemistry +12

Association between High Levels of Blood Macrophage Migration Inhibitory Factor, Inappropriate Adrenal Response, and Early Death in Patients with Severe Sepsis

Marieke Emonts, Fred C.G.J. Sweep, Nicolaï Grebenchtchikov et al. · Clinical Infectious Diseases · 2007 · 109 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.

Els M.J.J. Berns, Jan G.M. Klijn, Maxime P. Look et al. · PubMed · 2003 · 74 citations · Full text

Medicine, Genetics, Oncology +17

High‐sensitive radioimmunoassay for human serum hepcidin

Nicolaï Grebenchtchikov, Anneke Geurts‐Moespot, Joyce JC Kroot et al. · British Journal of Haematology · 2009 · 66 citations

Medicine, Biochemistry, Inflammation +12